Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on April 23, 2026

Midlife Cardiorespiratory Fitness Predicts How Well We Age
enQase Welcomes Mahi Dontamsetti to Advisory Board, Announces CTRO Content Series
Paywint Integrates Cross-Border Payments Infrastructure for Emerging Fintech Markets
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
Denta Biome Under Investigation: Adem Naturals Chewable Dental Tablets for Oral Health Care Support
C3HIE and THSA Create Texas’ Largest Interoperability Network
SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care
TriCelX Receives FDA Study May Proceed Letter for XytriX™
Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Chemed Reports First-Quarter 2026 Results
AVITA Medical to Announce First Quarter 2026 Financial Results
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
Trevi Therapeutics to Participate in Upcoming May Events
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions